U.S. CDC ADVISERS VOTE TO RECOMMEND PFIZER/BIONTECH COVID-19 VACCINE BOOSTER FOR PEOPLE BASED ON INDIVIDUAL BENEFIT-RISK WHO ARE AGED 18-49 YRS WITH UNDERLYING MEDICAL CONDITIONS